1 hr ago
Anupam Rasayan Gains Control of Bliss GVS Pharma
Anupam Rasayan bought a large number of shares in Bliss GVS Pharma.
The purchase cost about ₹162.74 crore.
After earlier purchases, Anupam Rasayan and its associate now own just over half of Bliss GVS Pharma.
This means they have gained control of the company.
They have also become its promoters.
Bliss GVS Pharma makes several kinds of medicines, including tablets, capsules and suppositories.
Anupam Rasayan said the deal will connect more parts of its pharmaceutical business.
The article gives different turnover figures for some financial years, so those figures should be read carefully.
Anupam Rasayan India acquired 22.5 lakh Bliss GVS Pharma shares for ₹162.74 crore.
The shares were purchased on-market at ₹723.2883 each, representing about 2.12% of Bliss GVS Pharma’s paid-up equity.
Anupam Rasayan and associate Mates Visa Consultancy now hold 5,32,36,264 shares, or 50.07% of Bliss GVS Pharma.
The companies gained control of Bliss GVS Pharma and were designated its promoters effective 28 September 2026.
Anupam Rasayan said the acquisition will support pharmaceutical value-chain integration, synergies and long-term growth.
- Who
- Anupam Rasayan India and its associate Mates Visa Consultancy acquired shares in Bliss GVS Pharma.
- What
- They acquired 22.5 lakh shares and increased their combined holding to 50.07%, gaining control and promoter status.
- Where
- The transaction was an on-market purchase involving Bliss GVS Pharma, a public listed company based in the company filing reported from Mumbai.
- When
- The acquisition was announced on Thursday; promoter designation was effective 28 September 2026.
- Why
- Anupam Rasayan said it sought greater presence across the pharmaceutical value chain, operational synergies and long-term growth.
Key facts
- Acquisition size
- 22,50,000 equity shares
- Purchase value
- ₹162.74 crore
- Price per share
- ₹723.2883
- Combined holding
- 5,32,36,264 shares, or 50.07% of Bliss GVS Pharma
- New status
- Anupam Rasayan and Mates Visa Consultancy were designated promoters and gained control
- Bliss GVS Pharma products
- Suppositories, pessaries, tablets, capsules and other specialty pharmaceutical products
- Target company incorporation
- 11 December 1984
Sources
Related news
Indian Stocks Spotlight Tata Restructuring, Deals and Expansion
Patel Chem Promoter Group Acquires 1,200 Shares Off-Market
Fosun Pharma Stake Sale Takes Holding Below 50%
Sudarshan Pharma Targets US Market With MedTherapy Stake Deal
Cupid Shares Rise After Promoter Buys 41 Lakh Shares
Anupam Rasayan Shares Fall After ₹160 Crore NCD Issue
Fuel Prices Remain Stable Across Major Indian Cities
ITAT Cancels Penalty for Late ITR Filing Without Under-reporting
Gold Prices Fall in Delhi, Mumbai and Kolkata
Rupee Opens 16 Paise Lower as Oil, Outflows Weigh
Angarki Sankashti Chaturthi 2026: Siddhivinayak Temple Announces Special Ritual Schedule
